Literature DB >> 1499352

Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus.

L Wu1, P S Morahan.   

Abstract

Mesh:

Year:  1992        PMID: 1499352     DOI: 10.1007/978-3-642-77247-4_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  10 in total

1.  Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

Authors:  Mark A Brockman; David M Knipe
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  SOCS1/3 expression levels in HSV-1-infected, cytokine-polarized and -unpolarized macrophages.

Authors:  Adam Craig Reichard; Nagarjuna Reddy Cheemarla; Nancy Jane Bigley
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

Review 3.  Experimental investigation of herpes simplex virus latency.

Authors:  E K Wagner; D C Bloom
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 4.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

5.  Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1.

Authors:  M A Brehm; R H Bonneau; D M Knipe; S S Tevethia
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice.

Authors:  K Ikemoto; T Utsunomiya; M A Ball; M Kobayashi; R B Pollard; F Suzuki
Journal:  Experientia       Date:  1994-05-15

7.  Uniocular anterior chamber inoculation of a tumor necrosis factor alpha-expressing recombinant of herpes simplex virus type 1 results in more rapid destruction and increased viral replication in the retina of the uninoculated eye.

Authors:  Mark A Fields; Mei Zheng; Pam Wall; Scott Oberg; Sally S Atherton
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

Review 8.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

9.  Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1.

Authors:  William P Halford; Jennifer L Maender; Bryan M Gebhardt
Journal:  Virol J       Date:  2005-07-17       Impact factor: 4.099

10.  The effect of aerobic exercise on immune biomarkers and symptoms severity and progression in patients with COVID-19: A randomized control trial.

Authors:  Ayman A Mohamed; Motaz Alawna
Journal:  J Bodyw Mov Ther       Date:  2021-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.